Abstract
Prion diseases are fatal neurodegenerative zoonotic foodborne disorders, which are caused by an abnormal isoform of prion protein (PrPSc) derived from the cellular isoform of prion protein (PrPC). According to epidemiological surveillance and in vivo experiments, exposure to the PrPSc during the weaning period is fraught with risk, suggesting that, during development, the intestinal defenses and the immune system are involved in PrPSc infection susceptibility. Although it remains unclear how PrPSc passes through the natural biological barriers during its invasion of intestinal cells, the 37 kDa/67 kDa laminin receptor is suspected to be one of the receptors involved in PrPSc-incorporation. In addition, we have recently shown that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, may play an important role in PrPSc incorporation. In this review, recent studies on PrPSc uptake and models of PrPSc incorporation into the intestine via the laminin and Fc receptors are described.
Keywords: Prion disease, PrPSc uptake, Fc receptor, neurodegenerative diseases, follicular dendritic cells, immunoglobulins, epithelial barriers, immunohistochemistry, laminin receptor precursors
Mini-Reviews in Organic Chemistry
Title: Penetration of Infectious Prion Protein in the Intestine During the Lactation Period
Volume: 9 Issue: 1
Author(s): Ryuta Uraki, Akikazu Sakudo, Yasuhisa Ano, Juri Kono, Masayoshi Yukawa, Gianluigi Zanusso, Antonio Toniolo and Takashi Onodera
Affiliation:
Keywords: Prion disease, PrPSc uptake, Fc receptor, neurodegenerative diseases, follicular dendritic cells, immunoglobulins, epithelial barriers, immunohistochemistry, laminin receptor precursors
Abstract: Prion diseases are fatal neurodegenerative zoonotic foodborne disorders, which are caused by an abnormal isoform of prion protein (PrPSc) derived from the cellular isoform of prion protein (PrPC). According to epidemiological surveillance and in vivo experiments, exposure to the PrPSc during the weaning period is fraught with risk, suggesting that, during development, the intestinal defenses and the immune system are involved in PrPSc infection susceptibility. Although it remains unclear how PrPSc passes through the natural biological barriers during its invasion of intestinal cells, the 37 kDa/67 kDa laminin receptor is suspected to be one of the receptors involved in PrPSc-incorporation. In addition, we have recently shown that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, may play an important role in PrPSc incorporation. In this review, recent studies on PrPSc uptake and models of PrPSc incorporation into the intestine via the laminin and Fc receptors are described.
Export Options
About this article
Cite this article as:
Uraki Ryuta, Sakudo Akikazu, Ano Yasuhisa, Kono Juri, Yukawa Masayoshi, Zanusso Gianluigi, Toniolo Antonio and Onodera Takashi, Penetration of Infectious Prion Protein in the Intestine During the Lactation Period, Mini-Reviews in Organic Chemistry 2012; 9 (1) . https://dx.doi.org/10.2174/157019312799079947
DOI https://dx.doi.org/10.2174/157019312799079947 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Systematic in-silico Analysis of Helicobacter pylori Pathogenic Islands for Identification of Novel Drug Target Candidates
Current Genomics Risk for Cervical Intraepithelial Neoplasia in Systemic Lupus Erythematosus is not Related to Disease Severity
Current Rheumatology Reviews Natural and Synthetic Retinoids: Structural Bases and Biological Effects of Potential Clinical Relevance for the Prevention and Treatment of Infection-Driven Tumors
Anti-Infective Agents in Medicinal Chemistry Osteoarthritis - An Update
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours
Current Pharmaceutical Design Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Oral Cavity-Associated Immune System: What is New?
Current Immunology Reviews (Discontinued) Recent Progress on Antifungal Drug Development
Current Pharmaceutical Biotechnology Up-Regulation of TLR-4 in the Brain After Ischemic Kidney-Induced Encephalopathy in the Rat
CNS & Neurological Disorders - Drug Targets Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles
Current Pharmaceutical Design 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer,s Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Current Alzheimer Research Conditional Tat Protein Brain Expression in the GT-tg Bigenic Mouse Induces Cerebral Fractional Anisotropy Abnormalities
Current HIV Research Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design Basolateral Aggregated Rat Amyloidβ(1-42) Potentiates Transmigration of Primary Rat Monocytes through a Rat Blood-Brain Barrier
Current Neurovascular Research The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Current Neuropharmacology Rabies Vaccines: The Third Generation
Letters in Drug Design & Discovery